BridgeMD
New treatment option for Tibial Fracture
Official title Tibial IMN Vs. Tibial Micromotion IMN
ClinicalTrials.gov ID: NCT06976801
What this study is testing
- What it's testing
- Our null hypothesis is that micromotion tibial intramedullary fixation (IMFN) does not impact union or complication rates when compared to standard of care treatment with non-micromotion tibial nail fixation. There are no current or past randomized controlled trials comparing these fixation techniques to one another.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 or older
- Unstable tibial fracture recommended for surgical intervention
You likely can't join if
- Patients not meeting inclusion criteria (Stable fracture patterns)
- Previously non-ambulatory patients
- Delayed presentation of fracture (\>4 weeks)
- Fractures that the treating surgeon indicates requires additional fixation strategies to achieve stability
- Patients with an active infection or wound at the surgical site
- Utilizing worker's compensation at the time of screening
See the full eligibility criteria
- Age 18 or older
- Unstable tibial fracture recommended for surgical intervention
- Patients not meeting inclusion criteria (Stable fracture patterns)
- Previously non-ambulatory patients
- Delayed presentation of fracture (\>4 weeks)
- Fractures that the treating surgeon indicates requires additional fixation strategies to achieve stability
- Patients with an active infection or wound at the surgical site
- Utilizing worker's compensation at the time of screening
- Any previous ligament or fracture surgery on the index site
- Inflammatory rheumatic disease or other rheumatic disease
- Immune compromised patients (hepatitis, HIV, etc.)
- Non-English-speaking patients
- Unwilling or unable to participate or follow study protocol
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.